Healthcare Value Capital, LLC

13F Filings History

Latest 13F report
Q3 2021 - Nov 15, 2021
Value $
$38.5M
Signature - Title
Thomas DesChamps - Managing Director, Portfolio Manager
Location
Woodcliff Lake, NJ
Summary
This page shows a list of all the recent 13F filings made by Healthcare Value Capital, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Healthcare Value Capital, LLC reported 18 stock holdings with total value $38.5M as of Q3 2021. Top holdings included GILD, GSKXXXX, PFE, ALKS, and AMYT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2021 18 $38.5M +$2.44M -$7.66M -$5.22M GILD, GSKXXXX, PFE, ALKS, AMYT 13F-HR 11/12/2021, 07:56 PM
Q2 2021 18 $46.2M +$9.13M -$1.3M +$7.83M GILD, GSKXXXX, PFE, ALKS, BMY 13F-HR 8/16/2021, 11:28 AM
Q1 2021 18 $39.2M +$23.7M -$12.8M +$10.8M GILD, PFE, GSKXXXX, CLVSQ, VYNE 13F-HR 5/17/2021, 08:27 AM
Q4 2020 17 $29.7M +$2.06M -$2.48M -$419K ABBV, GSKXXXX, VYNEXXXX, GILD, TYME 13F-HR 2/16/2021, 12:48 PM
Q3 2020 18 $30.3M +$6.89M -$2.04M +$4.85M GSKXXXX, JAZZ, GILD, ABBV, VYNEXXXX 13F-HR 11/16/2020, 08:48 AM
Q2 2020 19 $39.2M +$5.29M -$9.48M -$4.19M GSKXXXX, GILD, SPXUXXXX, MNLO, TYME 13F-HR 8/14/2020, 09:13 AM
Q1 2020 26 $59.5M +$36.3M -$2.98M +$33.3M ABBV, GSKXXXX, GILD, GILD, SPXUXXXX 13F-HR 5/15/2020, 08:47 AM
Q4 2019 16 $34M +$2.6M -$1.12M +$1.48M GSKXXXX, GILD, ABBV, CVS, TYME 13F-HR 2/14/2020, 01:02 PM
Q3 2019 22 $55.4M +$29.3M -$7.65M +$21.6M SPY, GILD, GSKXXXX, VIXYXXXX, ABBV 13F-HR 11/14/2019, 10:56 AM
Q2 2019 19 $53.3M +$36.3M +$36.3M GILD, SPY, GSKXXXX, GILD, ABBV 13F-HR 8/14/2019, 10:46 AM
Q1 2019 10 $26M +$10.1M +$10.1M AGN, GSKXXXX, TYME, GILD, LGND 13F-HR 5/14/2019, 05:09 PM
Q4 2018 10 $25.7M +$1.44M -$507K +$937K TYME, LAB, GSKXXXX, BIS, AGN 13F-HR 2/13/2019, 11:01 AM
Q3 2018 12 $41.3M +$1.02M -$1.71M -$687K GILD, AMRN, TYME, GSKXXXX, AGN 13F-HR 11/13/2018, 04:49 PM
Q2 2018 13 $35.3M +$10.6M +$10.6M GILD, TYME, NVLNF, GSKXXXX, AGN 13F-HR 8/7/2018, 04:13 PM
Q1 2018 9 $24.1M +$4M +$4M GILD, TYME, NVLNF, LAB, GSKXXXX 13F-HR 4/27/2018, 05:13 PM
Q4 2017 11 $32.9M +$964K +$964K TYME, GILD, GILD, NVLNF, LAB 13F-HR 1/23/2018, 12:05 PM
Q3 2017 12 $49.5M +$16.6M -$252K +$16.4M TYME, PFE, NVLNF, GILD, GILD 13F-HR 11/13/2017, 09:23 AM
Q2 2017 17 $55.7M +$14.4M +$14.4M PFE, NVLNF, DEPO, GILD, BIS 13F-HR 8/10/2017, 03:10 PM
Q1 2017 19 $58.5M +$5.06M -$20.3M -$15.2M NVLNF, PFE, SPY, GILD, DEPO 13F-HR 5/12/2017, 03:30 PM
Q4 2016 20 $93.3M +$54.5M -$3.09M +$51.4M SPY, ANIP, PFE, NVLNF, DEPO 13F-HR 2/10/2017, 09:53 AM
Q3 2016 20 $63.1M +$7.32M -$14.7M -$7.43M ANIP, DEPO, PFE, DGX, AMRI 13F-HR 11/10/2016, 02:02 PM
Q2 2016 26 $82.5M +$18.3M -$4.47M +$13.8M ANIP, SPY, DEPO, PFE, DGX 13F-HR 8/15/2016, 12:18 PM
Q1 2016 29 $67.9M +$21.4M -$969K +$20.4M ANIP, AMRI, PFE, SPY, DEPO 13F-HR 5/16/2016, 12:13 PM
Q4 2015 22 $60.5M +$4.29M -$3.81M +$485K ANIP, AMRI, QLTI, PFE, DGX 13F-HR 2/16/2016, 01:53 PM
Q3 2015 28 $70.1M +$18.2M -$9.02M +$9.22M ANIP, AMRI, AZN, QLTI, PFE 13F-HR 11/16/2015, 09:57 AM
Q2 2015 30 $95.2M +$43.4M -$6.43M +$37M AMRI, QLTI, BIS, MNKDXXXX, ANIP 13F-HR 8/14/2015, 09:47 AM
Q1 2015 36 $91.8M +$36.8M -$3.27M +$33.6M AZN, AMRI, TWM, AZN, TEVA 13F-HR 5/14/2015, 02:57 PM
Q4 2014 26 $54.7M +$14.7M -$5.56M +$9.16M AMRI, AZN, TEVA, DGX, PFE 13F-HR 2/13/2015, 12:13 PM
Q3 2014 32 $104M +$57.3M -$5.64M +$51.6M TWM, AMRI, ANIP, B108PS, B108PS 13F-HR 11/13/2014, 10:15 AM
Q2 2014 33 $119M +$26.9M -$4.72M +$22.2M SPY, TWM, IWM, AMRI, AZN 13F-HR 8/13/2014, 04:14 PM
Q1 2014 45 $153M +$80.4M -$38.2M +$42.2M SPY, MDY, TWM, AMRI, AUXL 13F-HR 5/13/2014, 12:24 PM
Q4 2013 36 $136M MDY, IBB, ANIP, SPY, TEVA 13F-HR 2/13/2014, 08:15 AM